AMBOSS
AMBOSS is a clinical reference and question-bank platform with an AI Mode that ranked first for safety in the 2024 Stanford-Harvard NOHARM benchmark for clinical AI.
- Pricing
- Paid Individual subscription. Strong adoption among medical students and residents.
- Availability
- Worldwide
- Languages
- English, German
- Vendor
- AMBOSS
- Overall score
- 6.8 See on The Index →
What it is
AMBOSS started as a USMLE / licensing-exam preparation platform and has expanded into clinical reference and AI-assisted bedside use. Its AI Mode ranked first in the 2024 Stanford-Harvard NOHARM safety study — the best independently-verified safety record at that time.
Where it stands out
- Best independently-verified safety record (NOHARM 2024).
- Strong fit for residents and medical students who already use AMBOSS for exam prep.
- German + English support useful in DACH-region practice.
Where it has limits
- Paid product; smaller corpus than UpToDate or DynaMed for complex inpatient medicine.
Frequently asked
- Is AMBOSS AI safe?
- AMBOSS AI Mode ranked first for safety in the 2024 Stanford-Harvard NOHARM benchmark for clinical AI, giving it the best independently-verified safety record among major clinical AI products at the time.
- Who uses AMBOSS?
- AMBOSS is widely used by medical students and residents preparing for licensing exams (USMLE in the US, equivalents elsewhere) and as a bedside reference during training.